Retraction Note: Mol Cancer 16, 48 (2017)
https://doi.org/10.1186/s12943-017-0615-x
The Editor-in-Chief has retracted this article. After a correction was published [1] to address concerns in a number of figures, additional concerns were raised, specifically:
-
Figure 2a: there appears to be overlap between the miR-NC and the sh-NC panels
-
Figure 2c: the sh-30d panel appears to be identical to the DU145 MYHPT1 panel of Supplementary figure 9c.
-
Supplementary Figure 5D: the 0h panels for miR-NC and miR-30d appear to be identical.
-
Supplementary Figure 6A: the sh-NC panel appears to overlap with the DU145 miR-30d+vector panel in figure 9a, but rotated.
-
Supplementary Figure 9A: the LNCaP Vector panel appears to overlap with the DU145 miR-30d+MYPT1 panel.
The Editor-in-Chief therefore no longer have confidence in the results and conclusions of this article.
Author Wei-De Zhong has stated on behalf of all authors that they agree with this retraction.
Reference
Lin Z, Chen G, Zhang Y, et al. Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer. Mol Cancer. 2019;18:122. https://doi.org/10.1186/s12943-019-1051-x.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Lin, Zy., Chen, G., Zhang, Yq. et al. Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer. Mol Cancer 22, 56 (2023). https://doi.org/10.1186/s12943-023-01763-5
Published:
DOI: https://doi.org/10.1186/s12943-023-01763-5